Vol. 41 No. 2 (2024)

Click for printable Cover

Published: 28-06-2024

  • Race and class in big data

    DOI: https://doi.org/10.36141/svdld.v41i2.16149
    Logan Harper, Daniel A Culver, Yvette C Cozier
    e2024001

  • Association of Area Deprivation Index with Adherence to Proposed Regimen in Patients with Sarcoidosis in Detroit, Michigan

    DOI: https://doi.org/10.36141/svdld.v41i2.15587
    Medha R Cherabuddi, Benjamin Goodman, Asem Ayyad, Dina A Almajali, Owais Nadeem, Patrick Bradley, Cori Russell, Daniel Ouellette
    e2024031

  • Predictive factors of mortality in patients with idiopathic pulmonary fibrosis treated with antifibrotics: a novel prognostic scoring system

    DOI: https://doi.org/10.36141/svdld.v41i2.13779
    Gülru Polat, Özer Özdemir, Sinem Ermin, Damla Serçe Unat, Fatma Demirci Üçsular
    e2024021

  • Prognostic value of coexisting conditions and complications in pleuroparenchymal fibroelastosis: a single-center retrospective study

    DOI: https://doi.org/10.36141/svdld.v41i2.13845
    Kazuhiko Iwasaki, Satoshi Watanabe, Kazumasa Kase, Noriyuki Ohkura, Keigo Saeki, Yuichi Tambo, Johsuke Hara, Miki Abo, Hideharu Kimura, Seiji Yano
    e2024014

  • Immunoglobulin G4-related thoracic disease: clinical and radiological findings of a Turkish cohort

    DOI: https://doi.org/10.36141/svdld.v41i2.14165
    Aslı Alkan, Gamze Durhan, Gozde Kubra Yardimci, Umran Ozden Sertcelik, Bayram Farisogullari, Macit Ariyurek, Omer Karadag, Deniz Koksal
    e2024030

  • The role for endobronchial biopsy in the era of endobronchial ultrasound guided transbronchial needle aspiration for the diagnosis of sarcoidosis: a single center experience Role for EBUS in the diagnosis of sarcoidosis

    DOI: https://doi.org/10.36141/svdld.v41i2.14192
    Roy Cho, Vidhay Pandey, Jennifer Wong, Joseph Keenan, Erhan Dincer, Emilian Racila, Tadashi Allen, David Perlman, Maneesh Bhargava
    e2024029

  • Investigation of respiratory muscle strength and its influence on exercise capacity and quality of life in patients with idiopathic pulmonary fibrosis IPF and Respiratory Muscle Strength

    DOI: https://doi.org/10.36141/svdld.v41i2.14884
    Esra Pehlivan, Melih Zeren, Elif Yelda Niksarlıoğlu, Fulya Senem Karaahmetoğlu, Zeynep Betül Özcan, Arif Balcı, Barış Demirkol, Erdoğan Çetinkaya
    e2024028

  • Osteoporotic bone fracture risk assessment in Latvian patients with newly diagnosed sarcoidosis

    DOI: https://doi.org/10.36141/svdld.v41i2.15156
    Ieva Ruza, Zane Lucane, Elina Vanaga, Marta Persana, Zane Vitenberga-Verza, Ilze Strumfa
    e2024020

  • Prognostic significance of body mass index and weight loss in patients with idiopathic pleuroparenchymal fibroelastosis

    DOI: https://doi.org/10.36141/svdld.v41i2.15291
    Masato Kono, Takahiko Saito, Tomo Tsunoda, Shin Ikeda, Takahiro Arano, Masayuki Watanuki , Mineo Katsumata, Hideki Miwa, Yoshihiro Miki, Dai Hashimoto, Takafumi Suda, Hidenori Nakamura
    e2024026

  • Comparison between diffuse and partial involvement of thoracic lymph nodes on the outcome of sarcoidosis patients

    DOI: https://doi.org/10.36141/svdld.v41i2.15336
    Ofir Persky, Michael Kassirer, Daniel Ostrovsky, Lydia Osyntsov, Yael Raviv
    e2024016

  • The role of biomarkers in the diagnosis and treatment follow-up of idiopathic pulmonary fibrosis

    DOI: https://doi.org/10.36141/svdld.v41i2.15454
    Abdullah kayıkçı, Fusun Alatas, I.Ozkan Alatas, Huseyın Yıldırım, Hulya Ozen
    e2024015

  • Pulmonary function in patients with ANCA-associated vasculitis

    DOI: https://doi.org/10.36141/svdld.v41i2.15577
    Johannes Dieterich, Bernhard Hellmich, Juliane Mahrhold, You-Shan Feng, Abdallah El Rai, Felix Nessyt, Ulrich Specks, Jürgen Hetzel, Christian Löffler
    e2024025

  • .

    Gingival hyperplasia and conjunctival inflammatory nodule: a diagnostic pathway to sarcoidosis?

    DOI: https://doi.org/10.36141/svdld.v41i2.15524
    Geethu Venugopalan, Rahul Bhandary, Amitha Ramesh
    e2024027

  • Bleomycin-induced pulmonary hypertension: an underrated phenomenon with important implications in the setting of high-risk clinical scenarios

    DOI: https://doi.org/10.36141/svdld.v41i2.15479
    Kenan Yalta, Cafer Zorkun, Ertan Yetkın
    e2024012

  • Salvage use of tofacitinib in sarcoidosis patient with refractory multiorgan involvement

    DOI: https://doi.org/10.36141/svdld.v41i2.15655
    Inês Farinha, Pedro Gonçalo Ferreira
    e2024019